Centerspace (CSR) Balance Sheet
As of 2026-06-30 (10-Q), Centerspace (CSR) reported total assets of $1.8B, total liabilities of $1.0B and shareholders' equity of $680.2M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $8.6M. Long-term debt: $989.6M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
CSRCenterspaceFollow CSR — free
—
Price chart with a free account
- Market cap
- 956.8M
- P/E TTM
- —
- Dividend yield
- 5.4%
- 52-week
- —
- Next earnings
- 2 Nov, in 9 days
| Line | FY2012 Apr 12 | FY2013 Apr 13 | FY2014 Apr 14 | FY2015 Apr 15 | FY2016 Apr 16 | FY2017 Apr 17 | FY2018 Apr 18 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 0.04 | 0.09 | 0.05 | 0.00 | 0.07 | 0.03 | 0.01 | 0.01 | 0.03 | 0.00 | 0.03 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Total assets | 1.71 | 1.89 | 1.87 | 2.00 | 1.76 | 1.47 | 1.43 | 1.34 | 1.39 | 1.46 | 1.94 | 2.03 | 1.93 | 1.91 | 1.93 | 1.84 | |
| Long-term debt | 1.05 | 1.05 | 1.00 | 0.60 | 0.81 | 0.57 | 0.51 | 0.44 | 0.33 | 0.30 | 0.86 | 1.01 | 0.92 | 0.96 | 1.02 | 0.99 | |
| Total liabilities | 1.15 | 1.13 | 1.14 | 1.25 | 1.03 | 0.83 | 0.73 | 0.69 | 0.70 | 0.77 | 0.92 | 1.07 | 0.98 | 1.01 | 1.08 | 1.04 | |
| Shareholders' equity | 0.43 | 0.61 | 0.59 | 0.65 | 0.62 | 0.55 | 0.61 | 0.57 | 0.62 | 0.62 | 0.77 | 0.73 | 0.71 | 0.75 | 0.72 | 0.68 |
USD billions · SEC XBRL
Centerspace — questions
- How much cash does Centerspace have?
- $8.6M in cash and cash equivalents as of 2026-06-30.
- How much debt does Centerspace have?
- $989.6M of long-term debt as of 2026-06-30.
- What are Centerspace's total assets?
- $1.8B as of 2026-06-30.
- What is Centerspace's shareholders' equity?
- $680.2M as of 2026-06-30.
Every figure on this page comes from Centerspace's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.